NASDAQ:RPTX
Delisted

Repare Therapeutics Stock Signals

etoro logo Buy RPTX
*Your capital is at risk
$2.65
+0 (+0%)
At Close: Apr 24, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Repare Therapeutics Inc.

General

Signal Type Signal Value Data
Score 0.000 107 days ( -23.26 %
Last Price $2.65 0 %
Performance History
7 Days
$2.65 $2.65
0%
30 Days
$2.65 $2.65
0%
12 Mos
$1.33 $2.65
99.25%

5/18

Active Buy Signals

Specific Signals

Short Term
Net score: 25
Signal Type Signal Value Importance Data
High / Low N/A Very Low $2.65 - $2.65
Trend - 3 mos 0.0696 % High Width: 0.735 %
Pred. range - 3 mos $2.63 - $2.65 Low -0.616 % - 0.114 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Sell Very Low Apr 23, 2026 - 2 days
RSI Short Pivot Signal Sell Very Low Jan 29, 2026 - 60 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 60.24
Signal Type Signal Value Importance Data
Trend - 12 mos 118.97 % Very High Width: 28.81 %
Pred. range - 12 mos $5.20 - $6.70 High 96.21 % - 152.73 %
Short MA 12 mos Buy Very High Dec 19, 2025 - 86 days
Long MA 12 mos Sell Very High Nov 13, 2025 - 111 days
Short/Long MA 12 mos Buy Very High May 08, 2025 - 242 days
Pivot Long Sell Low Apr 23, 2026 - 2 days
RSI Long Pivot Signal Sell Low Feb 09, 2026 - 53 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT REPARE THERAPEUTICS INC.
Repare Therapeutics
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that focuses on genomic instability, including DNA damage repair. Its lead product candidate is RP-3500, an ora...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE